NCT06314724View on ClinicalTrials.gov

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

PHASE3CompletedINTERVENTIONAL
Enrollment

642

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

September 6, 2024

Study Completion Date

September 6, 2024

Conditions
Varicella
Interventions
BIOLOGICAL

Varicella Vaccine

lyophilized powder,subcutaneous injection

BIOLOGICAL

Varivax

lyophilized powder,subcutaneous injection

Trial Locations (2)

1300

San Juan de Dios Educational Foundation, lnc., Pasay

1502

Cardinal Santos Medical Center, San Juan City

All Listed Sponsors
lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY

NCT06314724 - Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines | Biotech Hunter | Biotech Hunter